News

Back News

Emyria’s Managing Director, Dr Michael Winlo reflects on a great quarter

February 2, 2021
Emyria’s Managing Director, Dr Michael Winlo reflects on a great quarter

Emyria’s Managing Director, Dr Michael Winlo reflects on a great quarter in the Appendix 4C ASX Annoucement.

Read the full announcement here

Related posts

Emyria expands MDMA analogue program with the University of Western Australia
May 31, 2022

Emyria expands MDMA analogue program with the University of Western Australia

EMD-RX5 demonstrates excellent safety and bioavailability in Phase 1 study
May 25, 2022

EMD-RX5 demonstrates excellent safety and bioavailability in Phase 1 study

Dr Michael Winlo discusses future of psychedelics with SMH
May 17, 2022

Dr Michael Winlo discusses future of psychedelics with SMH

Have Questions?

If you have any question, please feel free to get in touch with us.

Contact Us

Hit enter to search or ESC to close

Call 08 6559 2800Contact